Celularity Inc. Amortization of Other Deferred Charges
Celularity Inc. (CELU) reported Amortization of Other Deferred Charges of $1.49 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherAmortizationOfDeferredCharges · last filed 2026-04-30
- Celularity Inc. amortization of other deferred charges for the quarter ending 2025-12-31 was $376.00K, a 0.00% change year-over-year.
- Celularity Inc. amortization of other deferred charges for the quarter ending 2025-09-30 was $376.00K, a 0.27% increase year-over-year.
- Celularity Inc. amortization of other deferred charges for the quarter ending 2025-06-30 was $372.00K, a 18.42% decline year-over-year.
- Celularity Inc. amortization of other deferred charges for the quarter ending 2025-03-31 was $368.00K.
- Celularity Inc. amortization of other deferred charges for fiscal 2025 was $1.49M, a 14.89% decline from fiscal 2024.
- Celularity Inc. amortization of other deferred charges for fiscal 2024 was $1.75M.
| Period end | Amortization of Other Deferred Charges 3 month | Amortization of Other Deferred Charges 6 month | Amortization of Other Deferred Charges 9 month | Amortization of Other Deferred Charges 12 month |
|---|---|---|---|---|
| 2025-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $752.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.12M derived: sum of 3 quarters · filed 2026-04-30 | $1.49M 10-K · filed 2026-04-30 |
| 2025-09-30 | $376.00K 10-Q · filed 2025-11-14 | $748.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.12M 10-Q · filed 2025-11-14 | $1.49M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-06-30 | $372.00K 10-Q · filed 2025-08-29 | $740.00K 10-Q · filed 2025-08-29 | $1.12M derived: sum of 3 quarters · filed 2026-04-30 | $1.49M derived: sum of 4 quarters · filed 2026-04-30 |
| 2025-03-31 | $368.00K derived: 10-K 12 month − 3 quarters · filed 2026-04-30 | $744.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.12M derived: sum of 3 quarters · filed 2026-04-30 | $1.57M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $376.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-30 | $751.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.21M derived: sum of 3 quarters · filed 2026-04-30 | $1.75M 10-K · filed 2026-04-30 |
| 2024-09-30 | $375.00K 10-Q · filed 2025-11-14 | $831.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.38M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $456.00K 10-Q · filed 2025-08-29 | $1.00M 10-Q · filed 2025-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |